BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Wednesday, September 3 at 2:45-3:15 PM ET. The live webcast will be available under the “Events & Presentations” tab on the “Investors” page of the Company’s website on the day of the event. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation. About Tango Therapeutics Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach...

WATERTOWN, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:Citi’s 2025 BioPharma Back to School ConferenceForum: Fireside ChatDate: Tuesday, September 2, 2025Time: 2:30 p.m. ETCantor Global Healthcare ConferenceForum: Fireside ChatDate: Wednesday, September 3, 2025Time: 2:45 p.m. ET Morgan Stanley 23rd Annual Global Healthcare Conference Forum: 1×1 Investor MeetingsDate: Tuesday, September 9, 2025A live webcast and subsequent archived replay of the presentations may be accessed via the Investors section of the Company website at www.eyepointpharma.com. About...

LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences:Citi’s 2025 Biopharma Back to School Conference: Fireside chat at 4:00 p.m. ET on Tuesday, September 2, 2025, in Boston, MA, during which the company plans to highlight preclinical data supporting its non-viral delivery platform leveraging novel receptor-binding molecules to transport multiple modalities of neurotherapeutics across the blood-brain barrier. 2025 Wells Fargo Healthcare Conference: Fireside chat at 4:30 p.m. ET on Wednesday, September 3, 2025, in Boston, MA. Cantor Global Healthcare Conference 2025: Fireside chat at 1:35 p.m. ET on...

EATONTOWN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), is excited to announce a strategic partnership with Coro. This partnership aims to leverage the strengths of both companies to deliver comprehensive cybersecurity solutions to a broader market. As cyber threats continue to evolve and SMBs and distributed enterprise face increasing security and compliance pressures, the demand for streamlined, scalable cybersecurity has never been greater. Coro’s unified platform meets this need, empowering channel partners to protect their customers from email threats, endpoint attacks, data loss, insider risks, and more through a single, integrated solution. “This partnership reinforces Coro’s commitment...

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:Citi’s 2025 BioPharma Back to School Conference with a fireside chat on Tuesday, September 2, 2025, at 4:45 p.m. ET. H.C. Wainwright 27th Annual Global Investment Conference with a company presentation on Monday, September 8, 2025, at 9:00 a.m. ET.A live webcast of these sessions will be available in the Investor section of the Company’s website at www.syndax.com, where a replay will also be available for a limited time. About Syndax Syndax Pharmaceuticals is a commercial-stage...

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences. Cantor Global Healthcare Conference – Fireside ChatDate: Thursday, September 4, 2025Time: 1:00 p.m. – 1:30 p.m. ETLocation: New York, NY Morgan Stanley 23rd Annual Global Healthcare ConferenceDate: Tuesday, September 9, 2025Location: New York, NY OPCO Targeted Radiopharmaceutical Therapies in Oncology Summit – Panel DiscussionsDate: Thursday, September 11, 2025Location: New York, NY Panel: Challenging Market...

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Amaero Limited (ASX: 3DA; OTCQX: AMROF), a company specializing in the research, development, manufacture, and sale of refractory metals and specialty alloy powders, has qualified to trade on the OTCQX® Best Market. Amaero LTD. upgraded to OTCQX from the OTCQB® Venture Market. Amaero Limited begins trading today on OTCQX under the symbol “AMROF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate...

SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences.Cantor Global Healthcare Conference in New York on September 3, 2025, with a fireside chat at 1:35 p.m. ET / 10:35 a.m. PT; and H.C. Wainwright 27th Annual Global Investment Conference in New York on September 9, 2025.A webcast of the Cantor fireside chat will be available in the Investors & Media section of Sagimet’s website at www.sagimet.com, with an archived replay available for 90 days following the live event. About Sagimet Biosciences  Sagimet is a clinical-stage biopharmaceutical company developing novel fatty...

WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced today that the management team will participate in three upcoming investor conferences in September 2025 as follows:Cantor Healthcare Conference: fireside chat at 8:00 am ET on Thursday, September 4th and available to host investor meetings September 3rd and 4th 2025 Wells Fargo Healthcare Conference: available to host investor meetings on September 5th H.C. Wainwright 26th Annual Global Investor Conference: presentation at 10:00 am ET on Tuesday, September 9th and available to host investor meetings September 8th and 9thA webcast of the fireside...